White scored tablets containing 100 mg or 500mg lincomycin (as lincomycin hydrochloride).

Antibiotic. For the treatment of infections such as infected dermatitis, abscesses, infected wounds, tonsillitis, laryngitis and metritis caused by lincomycin susceptible Gram-positive organisms, particularly streptococci and staphylococci.

Oral.
Dogs and cats
22 mg/kg body weight every 12 hours or 15 mg/kg bodyweight every 8 hours.

For animal treatment only. Keep out of the reach of children. Clinical antagonism may occur between lincomycin and erythromycin due to competitive binding at the ribosomal site of action. This antibiotic is not effective against Gram-negative aerobic organisms, Enterococcus faecalis or yeasts. Not recommended in species other than the cat and the dog. Loose stools have been observed occasionally in animals on high oral dosage but will usually self-correct without discontinuing medication. If the problem worsens, discontinue treatment.
Operator warnings
In case of accidental ingestion seek medical advice immediately and show the label to the doctor. People with known hypersensitivity to lincomycin should avoid contact with the product. Wash hands with soap and water after use.

Do not store above 25°C. Store in a dry place. Store in tightly closed original container.
Any unused product or waste material should be disposed of in accordance with national requirements.

POM-V (previously POM)

Supplied in plastic tubs of 100 x 100 mg tablets or 50 x 500 mg tablets.

Lincomycin is a lincosamide antibiotic with excellent activity against Gram-positive bacteria and certain Gram-negative anaerobic bacteria and mycoplasma. It is well absorbed and distributed throughout the body, particularly in areas of poor vascular supply. At the recommended dosage, supra-MIC levels are attained for the full interdose interval.